EPIZON Trademark

Trademark Overview

On Tuesday, November 17, 2015, a trademark application was filed for EPIZON with the United States Patent and Trademark Office. The USPTO has given the EPIZON trademark a serial number of 86984319. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2019. This trademark is owned by Epizon Pharma, Inc.. The EPIZON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart disease, osteoporosis, bone disease, renal disease, kidney disease, autoimmune disease, atherosclerosis, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reaction, anaphylaxis or asthma
epizon

General Information

Serial Number86984319
Word MarkEPIZON
Filing DateTuesday, November 17, 2015
Status700 - REGISTERED
Status DateTuesday, March 5, 2019
Registration Number5692098
Registration DateTuesday, March 5, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements

Description of MarkThe mark consists of the word "EPIZON" featuring a benzene ring as the "O".
Goods and Servicespharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart disease, osteoporosis, bone disease, renal disease, kidney disease, autoimmune disease, atherosclerosis, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reaction, anaphylaxis or asthma
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 20, 2015
Primary Code005
First Use Anywhere DateMonday, July 30, 2018
First Use In Commerce DateMonday, July 30, 2018

Trademark Owner History

Party NameEpizon Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoodbridge, CT 06525
Party NameEpizon Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoodbridge, CT 06525
Party NameEpizon Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodbridge, CT 06525

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 5, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, January 31, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 4, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 19, 2018USE AMENDMENT FILED
Thursday, January 3, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, December 19, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, December 19, 2018TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 19, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, November 29, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2018SOU EXTENSION 3 GRANTED
Friday, May 25, 2018SOU EXTENSION 3 FILED
Friday, May 25, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2017SOU EXTENSION 2 GRANTED
Monday, November 27, 2017SOU EXTENSION 2 FILED
Monday, November 27, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2017SOU EXTENSION 1 GRANTED
Wednesday, May 31, 2017SOU EXTENSION 1 FILED
Wednesday, May 31, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 5, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 11, 2017TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2016ASSIGNED TO LIE
Friday, August 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 11, 2016NON-FINAL ACTION E-MAILED
Friday, March 11, 2016NON-FINAL ACTION WRITTEN
Wednesday, March 9, 2016ASSIGNED TO EXAMINER
Saturday, November 21, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 20, 2015NEW APPLICATION ENTERED

Related Keywords

epizon disease treatment anaphylaxis pharmaceuticals asthma allergic systems devices drug reactions